Back to News
Market Impact: 0.5

1 Glorious Growth Stock Down 31% to Buy Hand Over Fist, According to Wall Street

ZSPANWCRWD
Cybersecurity & Data PrivacyArtificial IntelligenceTechnology & InnovationCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsProduct LaunchesCompany Fundamentals
1 Glorious Growth Stock Down 31% to Buy Hand Over Fist, According to Wall Street

Zscaler reported fiscal 2026 Q1 revenue of $788 million, a 26% year-over-year increase that beat management's $772M–$774M guide and accelerated from the prior quarter, prompting a modest raise in FY26 midpoint guidance to $3.292 billion. The company posted a GAAP loss of $11.6 million but delivered $159.5 million in adjusted net income, up 28% year-over-year, and highlighted product innovation (AI-SPM, Zero Trust Exchange/Branch) to address AI-driven cyber threats. Wall Street sentiment is largely positive — 32 of 50 tracked analysts rate the stock a buy with a consensus price target of $330.69 (≈31% upside) — while valuation metrics (P/S ~14.5) sit between peers, supporting a bullish investment case if revenue growth above ~25% persists.

Analysis

Market structure: AI-accelerated attacks increase demand for cloud-native, zero‑trust vendors — clear winners are ZS (Zero Trust Exchange/Branch), identity providers and AI-SPM specialists; losers are legacy perimeter firewall vendors and unmanaged branch estate owners who face higher refresh cycles. Zscaler’s 26% YoY revenue acceleration and P/S ~14.5 versus peers signals pricing power in SaaS security, but sustained share gains require continued 25%+ growth to justify multiples and the Street’s $330.69 (31%) target over 12–18 months. Risk assessment: Key tail risks are (1) a systemic breach of a major customer or Zscaler itself causing rapid churn, (2) regulatory constraints on AI/data sharing that could depress adoption, and (3) margin compression from competitive price cuts; any of these could trigger >20–40% downside. Near term (days–weeks) expect volatility around earnings/guidance, short term (3–6 months) the story will hinge on ARR/renewal lines, long term (2–5 years) the thesis depends on reaching the company’s $10B ARR pathway. Trade implications: Favor a constructive, risk‑managed exposure to ZS: primary play is a 12–18 month directional long funded by shorting higher‑valued peers; expect options IV to compress post‑print so prefer calendar/directional spreads rather than naked calls. Cross‑asset: tighter credit spreads in tech/cyber on positive prints; put buyers should watch rising event IV around major AI/regulatory headlines. Contrarian angles: Consensus underweights execution and competition risk — continued >25% growth is not guaranteed; if quarterly growth slips below ~20% we expect multiple compression toward the low‑teens P/S. Historical parallel: early cloud security winners have re‑rated then reversed when growth missed; therefore size positions to tolerate 20–30% drawdowns and use strike‑based hedges.